Enasidenib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Enasidenib is used to treat acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation in patients who have not responded to other treatments or to those whose cancer has come back after treatment.Enasidenib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Enasidenib Nitroso Impurity 2 CAS NO: NA chemically represented as N-(4-((2-Hydroxy-2-methylpropyl)(nitroso)amino)-6-(6-(trifluoromethyl)pyridin-2-yl)-1,3,5-triazin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)nitrous amide. Synchemia is the leading manufacturing and exporter of Enasidenib Nitroso Impurity 2 . We supply Enasidenib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141891 |
| CAS No | NA |
| Mol.F. | C28H19N5O9 |
| Mol.Wt. | 569.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141892 |
| CAS No | NA |
| Mol.F. | C25H19N5O6 |
| Mol.Wt. | 485.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141893 |
| CAS No | NA |
| Mol.F. | C33H27N7O9 |
| Mol.Wt. | 665.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141894 |
| CAS No | NA |
| Mol.F. | C26H21N5O6 |
| Mol.Wt. | 499.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141895 |
| CAS No | NA |
| Mol.F. | C32H42ClN3O16 |
| Mol.Wt. | 760.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141896 |
| CAS No | NA |
| Mol.F. | C30H33ClN4O9 |
| Mol.Wt. | 629.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141897 |
| CAS No | NA |
| Mol.F. | C24H28ClN3O10 |
| Mol.Wt. | 553.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141898 |
| CAS No | NA |
| Mol.F. | C21H26ClN3O6 |
| Mol.Wt. | 451.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141899 |
| CAS No | NA |
| Mol.F. | C19H22ClN3O6 |
| Mol.Wt. | 423.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141900 |
| CAS No | NA |
| Mol.F. | C20H21ClN2O6 |
| Mol.Wt. | 420.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141901 |
| CAS No | NA |
| Mol.F. | C25H30ClN3O10 |
| Mol.Wt. | 568.0 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141902 |
| CAS No | NA |
| Mol.F. | C20H24ClN3O6 |
| Mol.Wt. | 437.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141903 |
| CAS No | NA |
| Mol.F. | C20H26ClN3O6 |
| Mol.Wt. | 439.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141904 |
| CAS No | NA |
| Mol.F. | C31H29N9O5 |
| Mol.Wt. | 607.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141905 |
| CAS No | NA |
| Mol.F. | C18H20N6O3 |
| Mol.Wt. | 368.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141906 |
| CAS No | NA |
| Mol.F. | C14H15N3O3 |
| Mol.Wt. | 273.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |